ライフサイエンスコーパス: Stenotrophomonas maltophilia

1 ratia marcescens, Staphylococcus aureus, and Stenotrophomonas maltophilia).

2 he extensively drug resistant human pathogen Stenotrophomonas maltophilia.

3 structure of PabB from the emerging pathogen Stenotrophomonas maltophilia.

4 n Xylella fastidiosa and the human pathogen, Stenotrophomonas maltophilia.

5 talyzed by the dizinc L1 beta-lactamase from Stenotrophomonas maltophilia.

6 ermentative gram-negative bacilli, including Stenotrophomonas maltophilia.

7 t the important opportunistic human pathogen Stenotrophomonas maltophilia.

8 nterocolitica O9, Escherichia hermannii, and Stenotrophomonas maltophilia.

9 ound to L1 metallo-beta-lactamase (MBL) from Stenotrophomonas maltophilia.

10 acter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.

11 re identified by 16S rRNA gene sequencing as Stenotrophomonas maltophilia.

12 esistant Acinetobacter baumannii (CRAB), and Stenotrophomonas maltophilia.

13 esistant Acinetobacter baumannii (CRAB), and Stenotrophomonas maltophilia.

14 ureus [3 methicillin-resistant S. aureus], 2 Stenotrophomonas maltophilia, 1 Klebsiella pneumoniae) a

15 eumoniae, 2/4; Enterobacter cloacae 1/4; and Stenotrophomonas maltophilia 2/8.

16 losoxidans (33%), and finally, pan-resistant Stenotrophomonas maltophilia (20%).

17 4%), Acinetobacter baumannii (2/3, 67%), and Stenotrophomonas maltophilia (3/18, 17%).

18 scens (5.5%), Enterobacter aerogenes (4.4%), Stenotrophomonas maltophilia (4.3%), Proteus mirabilis (

19 mobacter xylosoxidans (100%) followed by MDR Stenotrophomonas maltophilia (46%), MDR Achromobacter xy

20 aphylococcus aureus, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter spp., and Bu

21 Staphylococcal aureus, Burkholderia cepacia, Stenotrophomonas maltophilia, Achromobacter xylosoxidans

22 tility against Burkholderia cepacia complex, Stenotrophomonas maltophilia, Acinetobacter baumannii an

23 We sequence 552 genomes of the pathogen Stenotrophomonas maltophilia across 23 sites of the lung

24 acter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia--all major threats to our c

25 ce determinant in the Gram-negative pathogen Stenotrophomonas maltophilia, an important cause of noso

26 s uncommon, occurring in 2 patients with MDR Stenotrophomonas maltophilia and 2 patients with MDR Ach

27 Stenotrophomonas maltophilia and Achromobacter (Alcalige

28 us all other Gram-negative ESKAPE pathogens, Stenotrophomonas maltophilia and biothreat pathogens.

29 (LUV) and to kill the Gram negative bacteria Stenotrophomonas maltophilia and Escherichia coli.

30 coccus spp., and the opportunistic pathogens Stenotrophomonas maltophilia and Ochrobactrum anthropi w

31 reviewed for Achromobacter xylosoxidans and Stenotrophomonas maltophilia and their antibiotic suscep

32 ve ( Pseudomonas species, Proteus mirabilis, Stenotrophomonas maltophilia ) and Gram-positive bacteri

33 ction of tobramycin-resistant P. aeruginosa, Stenotrophomonas maltophilia, and Achromobacter xylosoxi

34 ales (CRE), Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia c

35 elonged to Stenotrophomonas nitritireducens, Stenotrophomonas maltophilia, and Comamonas testosterone

36 s, Aeromonas caviae, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Enterococcus sp.

37 nct bacterial species: Cupriavidus gilardii, Stenotrophomonas maltophilia, and Geovibrio thiophilus.

38 Cultures confirmed Stenotrophomonas maltophilia, and oral trimethoprim-sulf

39 Klebsiella pneumoniae, Enterobacter cloacae, Stenotrophomonas maltophilia, and the Burkholderia cepac

40 Standard microbiology references describe Stenotrophomonas maltophilia as oxidase negative and var

41 tobacter species (non-baumannii complex) and Stenotrophomonas maltophilia at this time, and, as such,

42 erobacteriaceae spp, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Burkholderia cepacia, and

43 Stenotrophomonas maltophilia causes high-mortality infec

44 significantly, an extensively drug-resistant Stenotrophomonas maltophilia clinical isolate expressing

45 is a novel designation within the Stenotrophomonas maltophilia complex associated with iso

46 rmined to be a distinct component within the Stenotrophomonas maltophilia complex.

47 multidrug-resistant, opportunistic pathogen Stenotrophomonas maltophilia from 22 countries to infer

48 veil genetic characterization of contaminant Stenotrophomonas maltophilia habouring antibiotic resist

49 ta-lactamase from the opportunistic pathogen Stenotrophomonas maltophilia has been determined at 1.7

50 Background Stenotrophomonas maltophilia has increasingly become a s

51 Stenotrophomonas maltophilia has plant growth-promoting

52 Stenotrophomonas maltophilia has recently emerged as an

53 patients with Achromobacter xylosoxidans and Stenotrophomonas maltophilia have similar posttransplant

54 merging pathogens Pseudomonas aeruginosa and Stenotrophomonas maltophilia increased significantly dur

55 esistant Acinetobacter baumannii (CRAB), and Stenotrophomonas maltophilia infections.

56 Metallo-beta-lactamase L1 from Stenotrophomonas maltophilia is a dinuclear Zn(II) enzym

57 Stenotrophomonas maltophilia is a Gram-negative bacteriu

58 Stenotrophomonas maltophilia is a Gram-negative bacteriu

59 Stenotrophomonas maltophilia is a gram-negative bacteriu

60 Stenotrophomonas maltophilia is a multiple-antibiotic-re

61 Stenotrophomonas maltophilia is a ubiquitous bacterium a

62 Stenotrophomonas maltophilia is an emerging opportunisti

63 Stenotrophomonas maltophilia is an emerging opportunisti

64 Stenotrophomonas maltophilia is an emerging, opportunist

65 Stenotrophomonas maltophilia is difficult to treat due t

66 Stenotrophomonas maltophilia is increasingly common in p

67 The Gram-negative bacterium Stenotrophomonas maltophilia is increasingly identified

68 Stenotrophomonas maltophilia is intrinsically resistant

69 The L1 metallo-beta-lactamase from Stenotrophomonas maltophilia is unique among this class

70 L1, a class B3 enzyme expressed by Stenotrophomonas maltophilia, is a significant contribut

71 pan-resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia, is poorly characterized.

72 seobacterium meningosepticum isolates, and 1 Stenotrophomonas maltophilia isolate) producing IMP-1, I

73 26 Acinetobacter baumannii isolates, and 11 Stenotrophomonas maltophilia isolates.

74 , Escherichia coli, Serratia marcescens, and Stenotrophomonas maltophilia isolates.

75 rized a polysaccharide lyase (Smlt1473) from Stenotrophomonas maltophilia k279a, which exhibited sign

76 c mechanism of beta-lactam hydrolysis by the Stenotrophomonas maltophilia L1 metallo-beta-lactamase.

77 ese were found to be P. aeruginosa (n = 10), Stenotrophomonas maltophilia (n = 1), and Burkholderia c

78 nt Stenotrophomonas maltophilia (n = 5), MDR Stenotrophomonas maltophilia (n = 26), and CF patients w

79 s mirabilis (n = 3), Serratia spp. (n = 10), Stenotrophomonas maltophilia (n = 43), Sphingobacterium

80 m-resistant Pseudomonas aeruginosa (n = 25), Stenotrophomonas maltophilia (n = 46), and Myroides sp.

81 obacter xylosoxidans (n = 15), pan-resistant Stenotrophomonas maltophilia (n = 5), MDR Stenotrophomon

82 8, n = 4, n = 3, n = 3, n = 17), and one of Stenotrophomonas maltophilia (n = 8).

83 patients without Achromobacter xylosoxidans, Stenotrophomonas maltophilia or Bulkholderia cenocepacia

84 increase isolation of Burkholderia cepacia, Stenotrophomonas maltophilia, or Alcaligenes xylosoxidan

85 arbapenem-resistant Acinetobacter baumannii, Stenotrophomonas maltophilia, or New Delhi metallo-B-lac

86 smid pB10 was shown to be highly unstable in Stenotrophomonas maltophilia P21 and Pseudomonas putida

87 maintained against Acinetobacter baumannii, Stenotrophomonas maltophilia, Staphylococcus aureus, Sta

88 Smlt1473 present in the clinically relevant Stenotrophomonas maltophilia strain K279a demonstrates a

89 To achieve the objective, Stenotrophomonas maltophilia strain ZL1 was used as a mo

90 rains, 5 Alcaligenes xylosoxidans strains, 5 Stenotrophomonas maltophilia strains, and 5 Pseudomonas

91 trains, 10 Pseudomonas aeruginosa strains, 8 Stenotrophomonas maltophilia strains, and 9 isolates bel

92 With the exception of Stenotrophomonas maltophilia, these organisms are infreq

93 chromosomal carbapenemases are restricted to Stenotrophomonas maltophilia, to a few Bacteroides fragi

94 ionella pneumophila, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Vibrio cholerae, and Yersi

95 3 of [corrected] 35 home-use nebulizers, and Stenotrophomonas maltophilia was isolated from 4 of 35 h

96 Stenotrophomonas maltophilia was isolated from the respi

97 trocefin with metallo-beta-lactamase L1 from Stenotrophomonas maltophilia was studied using rapid-sca

98 P assay is the absence of fungal targets and Stenotrophomonas maltophilia, which were detected in 26

99 Stenotrophomonas maltophilia WR-C is capable of forming